EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN

A. A. Ruleva; S. M. Kharit; E. P. Nacharova; I. V. Fridman

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

User

eng | рус

Pediatric pharmacology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Ruleva A.A., Kharit S.M., Nacharova E.P., Fridman I.V. EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN. Pediatric pharmacology. 2013;10(1):70-73. https://doi.org/10.15690/pf.v10i1.591

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Editor-in-Chief

Leyla S. Namazova-Baranova

Popular articles

* not an advertisement

Indexing Databases

* not an advertisement

Article Tools

Abstract

Print this article

Indexing metadata

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

A. A. Ruleva
Research institute of children’s infections at the Federal Medical-Biological Agency, Saint Petersburg, Russian Federation

Junior research scientist at the infectious diseases’ prevention department, FSBI “Research institute of children’s infections at the FMBA of Russia”.

S. M. Kharit
Research institute of children’s infections at the Federal Medical-Biological Agency, Saint Petersburg, Russian Federation

E. P. Nacharova
Research institute of children’s infections at the Federal Medical-Biological Agency, Saint Petersburg, Russian Federation

I. V. Fridman
Research institute of children’s infections at the Federal Medical-Biological Agency, Saint Petersburg, Russian Federation

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Pediatric pharmacology

For citations:

Cookies policy